Showing results (321-330 of 364) with videos related to

Sort By:
Pageof 37
Medicine|November 18, 2017
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agentsChao-Min Huang, Tsung-Hui Hu, Kuo-Chin Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 4, 2020
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general populationMing-Lung Yu, Pei-Jer Chen, Chia-Yen Dai, et al.
Journal of Hepatology|November 17, 2009
Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesisYing-Hsien Kao, Chao-Long Chen, Bruno Jawan, et al.
Scientific Reports|June 7, 2018
A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort studyKung-Hao Liang, Sang Hoon Ahn, Hye Wong Lee, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 7, 2023
TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetesMing-Lung Yu, Chih-Yuan Wang, Mei-Hsuan Lee, et al.
Oncotarget|May 5, 2015
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesisSan-Cher Chen, Tsung-Hui Hu, Chao-Cheng Huang, et al.
The American Journal of Gastroenterology|September 1, 2021
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal DiseaseWan-Long Chuang, Tsung-Hui Hu, Peter Buggisch, et al.
Biomed Research International|June 20, 2015
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori EradicationWei-Chen Tai, Chih-Ming Liang, Chen-Hsiang Lee, et al.
Oncotarget|April 12, 2014
Celecoxib suppresses hepatoma stemness and progression by up-regulating PTENTian-Huei Chu, Hoi-Hung Chan, Hsiao-Mei Kuo, et al.
Japanese Journal of Radiology|February 5, 2026
Intensity-modulated proton therapy for patients with unresectable giant (≥ 10 cm) hepatocellular carcinoma: a retrospective analysis from two high-volume centersJen-Yu Cheng, Yu-Ming Wang, Yen-Hao Chen, et al.
Pageof 37